Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01300832 · ClinicalTrials.gov registry record · NA

The Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
271
Enrollment target

NCT01300832: Completed NA study, sponsored by University of Illinois at Chicago.

NCT01300832 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 271 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01300832, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
271 participants
Enrollment target

Study Summary

The study's hypothesis is that there are some patients who come for surgery who have asymptomatic clots in their lower extremities upon their arrival to the hospital for their surgical admission. We will be performing duplex studies of the subjects' legs before their surgery to determine how often clots are present. We will also perform duplex scans of the legs after the subjects' surgeries to determine what factors (surgical, anesthetic, co-morbidities)are correlated with the development of DVTs.

Interventions

  • PROCEDURE Duplex scan of lower extremities

Trial Details

FieldValue
Enrollment Target 271 participants
Start Date 2011-02-01
Est. Completion 2022-12-01
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT01300832 record still lists

NCT01300832 is an interventional study that assigns participants to a tested intervention. The registered 271 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Duplex scan of lower extremities is the first listed.

NCT01300832 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01300832 about?

NCT01300832 is a clinical study titled "The Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities". The study's hypothesis is that there are some patients who come for surgery who have asymptomatic clots in their lower extremities upon their arrival to the hospital for their surgical admission. We will be performing duplex studies of the subjects' legs before their surgery to determine how often c...

What is the current status of trial NCT01300832?

This trial is currently completed. It is a NA study. The enrollment target is 271 participants. The study started on 2011-02-01. Estimated completion is 2022-12-01.

What interventions are being tested in trial NCT01300832?

The interventions under investigation include: Duplex scan of lower extremities (PROCEDURE).

Who is sponsoring clinical trial NCT01300832?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01300832's enrollment target sits among peer trials

271 387th of 2000 higher than 1,614 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03609216 · 271 participants · Phase 2

    Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

  • NCT02468024 · 272 participants · Phase 3

    JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

  • NCT05519449 · 272 participants · Phase 1

    Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • NCT06035939 · 272 participants · NA

    SMYLS Multi-site Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01300832, the US trial registry maintained by the National Library of Medicine. NCT01300832 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.